🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Glenmark Arzneimittel GmbH — Licensed Medicines

20 medicines held by Glenmark Arzneimittel GmbH on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 20 products held by Glenmark Arzneimittel GmbH
MedicineActive substanceLicence holderStatus
Apremilast Glenmark 10 mg + 20 mg + 30 mg film-coated tablets
PA22645/007/001
 Apremilast, Apremilast, Apremilast Glenmark Arzneimittel GmbH Not marketed
Apremilast Glenmark 30mg film-coated tablets
PA22645/007/002
 Apremilast Glenmark Arzneimittel GmbH Not marketed
Atovaquone/Proguanil Hydrochloride 250 mg /100 mg film-coated tablets
PA22645/006/001
 Atovaquone, PROGUANIL HYDROCHLORIDE Glenmark Arzneimittel GmbH Not marketed
Desloratadine Glenmark 5 mg tablets
PA22645/004/001
 Desloratadine Glenmark Arzneimittel GmbH Not marketed
Escitalopram Glenmark 10 mg film-coated tablets
PA22645/005/002
 Escitalopram Glenmark Arzneimittel GmbH Not marketed
Escitalopram Glenmark 15 mg film-coated tablets
PA22645/005/003
 Escitalopram Glenmark Arzneimittel GmbH Not marketed
Escitalopram Glenmark 20 mg film-coated tablets
PA22645/005/004
 Escitalopram Glenmark Arzneimittel GmbH Not marketed
Escitalopram Glenmark 5 mg film-coated tablets
PA22645/005/001
 Escitalopram Glenmark Arzneimittel GmbH Not marketed
Levocetirizine Glenmark 5 mg Film-coated Tablets
PA22645/003/001
 Levocetirizine dihydrochloride Glenmark Arzneimittel GmbH Not marketed
Nebivolol 10mg tablets
PA22645/002/001
 Nebivolol hydrochloride Glenmark Arzneimittel GmbH Not marketed
Olanzapine Glenmark 10 mg tablets
EU/1/09/587/10-12
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark 15 mg tablets
EU/1/09/587/13-15
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark 2.5 mg tablets
EU/1/09/587/1-3
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark 20 mg tablets
EU/1/09/587/16-17
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark 5 mg tablets
EU/1/09/587/4-6
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark 7.5 mg tablets
EU/1/09/587/7-9
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark Europe 10 mg orodispersible tablets
EU/1/09/588/4-6
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark Europe 15 mg orodispersible tablets
EU/1/09/588/7-9
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark Europe 20 mg orodispersible tablets
EU/1/09/588/10-12
 Olanzapine Glenmark Arzneimittel GmbH —
Olanzapine Glenmark Europe 5 mg orodispersible tablets
EU/1/09/588/1-3
 Olanzapine Glenmark Arzneimittel GmbH —
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.